prescript-drugs-affect-young-adults_0

NIH and FDA leaders call for innovation in development of smoking cessation treatments
Higher doses of buprenorphine may improve treatment outcomes for people with opioid use disorder
Fewer than half of U.S. jails provide life-saving medications for opioid use disorder
Cannabis and hallucinogen use among adults remained at historic highs in 2023
NIH launches program to advance research led by Native American communities on substance use and pain
Doctors reluctant to treat addiction most commonly report “lack of institutional support” as barrier